Floatz logo

N-Acetyl-L-Cysteine

Platelet Storage Pool Deficiency

National Human Genome Research Institute (NHGRI)Phase 2Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Platelet Storage Pool Deficiency cohort.

Asset / SponsorPhaseRating
Pirfenidone
William Gahl, M.D.
Phase 2B
Zileuton
National Human Genome Research Institute (NHGRI)
Phase 1/2CCC
Losartan
National Human Genome Research Institute (NHGRI)
Phase 1/2CCC
Erythromycin
National Human Genome Research Institute (NHGRI)
Phase 1/2CCC
PRAVASTATIN
National Human Genome Research Institute (NHGRI)
Phase 1/2CCC

Same molecule, other indications

N-Acetyl-L-Cysteine is also rated in:

idiopathic pulmonary fibrosisDormant
BBB
Indicative ·
74 / 100
View asset →
schizophreniform disorderDormant
BBB
Indicative ·
74 / 100
View asset →
traumatic brain injuryDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →